Efficacy/safety of entinostat (ENT) and pembrolizumab (PEMBRO) in NSCLC patients previously treated with anti-PD-(L) 1 therapy Meeting Abstract
| Authors: | Hellmann, M.; Jänne, P.; Opyrchal, M.; Hafez, N.; Raez, L.; Gabrilovich, D.; Wang, F.; Ordentlich, P.; Brouwer, S.; Sankoh, S.; Schmidt, E.; Meyers, M.; Ramalingam, S. |
| Abstract Title: | Efficacy/safety of entinostat (ENT) and pembrolizumab (PEMBRO) in NSCLC patients previously treated with anti-PD-(L) 1 therapy |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | monocytes; entinostat; pembrolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S330 |
| Language: | English |
| ACCESSION: | WOS:000454014500241 |
| DOI: | 10.1016/j.jtho.2018.08.257 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA05.01 -- Source: Wos |
